The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
232 - Are sales representatives are allowed to detail on unbranded disease messages, and product-specific messages for this disease in the same sales call, even if the messages are presented in separate APS? I'm concerned about the concept of linking unbranded messages to branded claims.
-
I can see why you'd be concerned. This activity would inherently brand the non-branded piece through linkage. If the non-branded piece contains content which would not be accepted in a branded context, this activity would contravene the regs.
Whenever linking separate materials/activities, always pause to examine whether the linkage would change the regulatory status of those materials.
